organophosphonates has been researched along with Body Weight in 54 studies
*Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (24.07) | 18.7374 |
1990's | 4 (7.41) | 18.2507 |
2000's | 21 (38.89) | 29.6817 |
2010's | 14 (25.93) | 24.3611 |
2020's | 2 (3.70) | 2.80 |
Authors | Studies |
---|---|
Makino, K; Takeuchi, I; Tanaka, K | 1 |
Atar, S; Bernaud, C; Fahrni, G; Frenoux, JM; Hmissi, A; Moccetti, T; Mueller, C; Schelfaut, D; Sinnaeve, P; Spirito, A; Ufer, M; Valgimigli, M | 1 |
Brundage, T; Dunn, JA; Foster, SA; Gainey, MR; Grossi, IM; Khouri, JM; Krile, RT | 1 |
Baldelli, S; Castagnoli, L; Cattaneo, D; Clementi, E; Fucile, S; Galli, M; Gervasoni, C; Landonio, S; Meraviglia, P; Riva, A; Rizzardini, G | 1 |
Asin-Prieto, E; Derendorf, H; Samara, E; Sy, SK | 1 |
Balakrishnan, L; Buller, RM; Capella, C; Dewhurst, S; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B | 1 |
Aoki, T; Gatanaga, H; Honda, H; Kawasaki, Y; Kikuchi, Y; Kinai, E; Mizushima, D; Nishijima, T; Oka, S; Tanaka, N; Tanuma, J; Teruya, K; Tsukada, K; Watanabe, K; Yazaki, H | 1 |
Buller, RM; Spencer, JF; Tollefson, AE; Toth, K; Wold, WS; Ying, B | 1 |
Rijnders, BJ; Rokx, C; Van der Ende, ME | 1 |
Gatanaga, H; Kawasaki, Y; Nishijima, T; Oka, S; Tanaka, N | 1 |
Atté, EF; Rasschaert, F; Reid, T; van Griensven, J; Zachariah, R | 1 |
Kamata, K; Kobayashi, T; Matsumoto, T; Ozawa, Y; Taguchi, K | 1 |
Bowonwatanuwong, C; Chaisiri, K; Kasettratat, N; Kiertiburanakul, S | 1 |
Aoki, T; Gatanaga, H; Honda, H; Honda, M; Kikuchi, Y; Kinai, E; Komatsu, H; Nishijima, T; Oka, S; Tanuma, J; Teruya, K; Tsukada, K; Watanabe, K; Yazaki, H | 1 |
Ennis, J; Russell, A; Smee, DF; Turner, JD; Wong, MH | 1 |
Aoki, T; Gatanaga, H; Honda, H; Honda, M; Kikuchi, Y; Kinai, E; Komatsu, H; Nishijima, T; Oka, S; Shimbo, T; Tanuma, J; Teruya, K; Tsukada, K; Watanabe, K; Yazaki, H | 1 |
Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E | 1 |
Daniel, N; de Boever, CM; Leray, H; Mauboussin, JM; Moachon, L; Peyrière, H; Reynes, J; Rouanet, I; Salmon-Céron, D; Vincent, D | 1 |
Bailey, KW; Beadle, JR; Hostetler, KY; Sidwell, RW; Smee, DF; Wong, MH | 1 |
Froestl, W; Markou, A; Paterson, NE | 1 |
Beque, MC; Braga, AL; de Avila, DS; Folmer, V; Nogueira, CW; Rocha, JB; Soares, FA; Zeni, G | 1 |
Chandramouli, VC; Dang, Q; Erion, MD; Landau, BR; Potter, SC; van Poelje, PD | 1 |
Cirino, CM; Kan, VL | 1 |
Bogner, J; Claas, GJ; Goebel, FD; Jülg, B | 1 |
Ananworanich, J; Chetchotisakd, P; Gayet-Ageron, A; Hirschel, B; Jupimai, T; Le Braz, M; Prasithsirikul, W; Rooney, JF; Ruxrungtham, K; Ubolyam, S | 1 |
Alves, D; Avila, DS; Dalla Corte, CL; Gubert, P; Nogueira, CW; Rocha, JB; Soares, FA | 1 |
Bischofberger, N; Chen, SS; Clotet, B; Cooper, DA; Curtis, S; Gazzard, B; Katlama, C; Lange, J; Lazzarin, A; Montaner, JS; Nelson, MR; Rooney, JF; Schewe, K; Smith, S; Wyatt, C | 1 |
Crane, HM; Harrington, RD; Kestenbaum, B; Kitahata, MM | 1 |
Baldwin, TJ; Gowen, BB; Hoopes, JD; Sidwell, RW; Skirpstunas, RT; Smee, DF; Wandersee, MK; Wong, MH | 1 |
Galiev, MA; Suleĭmanov, RA | 1 |
Andrei, G; De Clercq, E; Liekens, S; Neyts, J; Vandeputte, M | 1 |
Bischofberger, N; Cundy, K; Marthas, ML; Shaw, JP; Tarantal, AF | 1 |
Bolger, G; Bousquet, C; Cordingley, M; Garneau, M; Kibler, P; Lapeyre, N; Rhéaume, M | 1 |
Battistini, B; Cloutier, R; Fournier, L; Jean, S; Jeng, AY; Kavanagh, M; Kluth, D; Major, D | 1 |
Bailey, KW; Sidwell, RW; Smee, DF | 2 |
Galofré, JC; Idoate, M; Redondo, P; Solano, T | 1 |
Bailey, KW; Sidwell, RW; Smee, DF; Wong, MH | 1 |
Bischofberger, N; Castillo, A; Ekert, JE; Martin, RB; Tarantal, AF | 1 |
Bray, M; Kefauver, D; Martinez, M; Roy, C; West, M | 1 |
Goulding, A; Malthus, RS; McChesney, R | 1 |
Bonjour, JP; Fleisch, H; Russell, RG; Schenk, R; Trechsel, U | 1 |
Berezin, F; Janisch, L; Mick, R; Ratain, MJ; Schilsky, RL; Smiddy, J; Williams, SF | 1 |
Burkova, T; Ivanova-Chemishanska, L; Kapurdov, V; Mikhaĭlova, A; Zaĭkov, Kh | 1 |
Boorman, GA; Cardy, RH; Dunnick, JK; Haseman, JK; Langloss, J; Manus, AG | 1 |
Lane, JM; Steinberg, ME | 1 |
Buehler, EV; Nolen, GA | 1 |
Rosenblum, IY | 1 |
Anbar, M; Newell, GW; St John, GA | 1 |
Buehler, EV; Newmann, EA; Nixon, GA | 1 |
Francis, MD; King, WR; Michael, WR | 1 |
Alvarez Fuertes, G; González Barranco, D; Salazar Mallén, M | 1 |
Short, CR; Wagstaff, DJ | 1 |
6 trial(s) available for organophosphonates and Body Weight
Article | Year |
---|---|
Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial Infarction.
Topics: Adult; Aged; Aged, 80 and over; Body Weight; Clopidogrel; Drug Therapy, Combination; Female; Humans; Injections, Subcutaneous; Male; Middle Aged; Myocardial Infarction; Organophosphonates; Patient Safety; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Pyrimidines; Ticagrelor; Treatment Outcome | 2020 |
Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Bone Resorption; Female; HIV Infections; Humans; Middle Aged; Organophosphonates; Risk Factors; Tenofovir | 2013 |
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe | 2012 |
A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Antiviral Agents; Body Weight; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Fanconi Syndrome; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Male; Organophosphonates; RNA, Viral; Treatment Outcome | 2002 |
Metabolic and anthropometric changes one year after switching from didanosine/stavudine to tenofovir in HIV-infected patients.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Body Weight; CD4 Lymphocyte Count; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatinine; Didanosine; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Hemoglobins; HIV Infections; Humans; Lactic Acid; Male; Middle Aged; Organophosphonates; Phosphates; Skinfold Thickness; Stavudine; Tenofovir; Treatment Outcome; Triglycerides; Uric Acid; Viral Load | 2007 |
No change in calculated creatinine clearance after tenofovir initiation among Thai patients.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Body Weight; Creatinine; Female; HIV Infections; Humans; Kidney; Kidney Function Tests; Lamivudine; Male; Organophosphonates; Tenofovir; Thailand | 2007 |
48 other study(ies) available for organophosphonates and Body Weight
Article | Year |
---|---|
Therapeutic Effects of GGsTop
Topics: Aminobutyrates; Animals; Antimetabolites, Antineoplastic; Body Weight; Collagen; Disease Models, Animal; Drug Dosage Calculations; Fluorouracil; Gels; Glutathione; Leukocytes; Male; Mice; Organophosphonates; Stomatitis | 2021 |
Efficacy of delayed brincidofovir treatment against a lethal rabbitpox virus challenge in New Zealand White rabbits.
Topics: Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Body Temperature; Body Weight; Cytosine; Disease Models, Animal; Double-Blind Method; Organophosphonates; Poxviridae Infections; Rabbits; Smallpox; Survival Rate; Treatment Outcome; Vaccination; Vaccinia; Vaccinia virus; Variola virus; Viral Load | 2017 |
Predicting pediatric age-matched weight and body mass index.
Topics: Adenine; Adolescent; Aging; Body Mass Index; Body Weight; Child; Child, Preschool; Computer Simulation; Female; Humans; Infant; Infant, Newborn; Male; Models, Biological; Models, Statistical; Organophosphonates; Predictive Value of Tests; Software; Tenofovir | 2014 |
Ganciclovir inhibits human adenovirus replication and pathogenicity in permissive immunosuppressed Syrian hamsters.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Body Weight; Cell Line, Tumor; Cytosine; DNA-Directed DNA Polymerase; Female; Ganciclovir; Gene Expression; Humans; Immunocompromised Host; Male; Mesocricetus; Organophosphonates; Survival Analysis; Transaminases; Viral Load; Viral Proteins; Virus Replication | 2014 |
Long-term exposure to tenofovir continuously decrease renal function in HIV-1-infected patients with low body weight: results from 10 years of follow-up.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Longitudinal Studies; Male; Organophosphonates; Renal Insufficiency; Tenofovir; Tokyo | 2014 |
Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Alanine Transaminase; Animals; Body Weight; Cell Line; Cidofovir; Cytosine; Disease Models, Animal; Female; Humans; Immunocompromised Host; Liver; Mesocricetus; Organophosphonates; Ribavirin; Survival Analysis; Treatment Outcome; Viral Load | 2014 |
How does weight influence tenofovir disoproxil-fumarate induced renal function decline?
Topics: Adenine; Anti-HIV Agents; Body Weight; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Organophosphonates; Renal Insufficiency | 2015 |
Reply to 'how does weight influence tenofovir disoproxil-fumarate induced renal function decline?'.
Topics: Adenine; Anti-HIV Agents; Body Weight; Female; Glomerular Filtration Rate; HIV Infections; Humans; Male; Organophosphonates; Renal Insufficiency | 2015 |
Weight evolution in HIV-1 infected women in Rwanda after stavudine substitution due to lipoatrophy: comparison of zidovudine with tenofovir/abacavir.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Dideoxynucleosides; Drug Therapy, Combination; Female; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Organophosphonates; Rwanda; Stavudine; Tenofovir; Treatment Outcome; Weight Loss; Zidovudine | 2009 |
Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
Topics: Animals; Aspartic Acid Endopeptidases; Benzofurans; Blood Glucose; Body Weight; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin-1; Endothelin-Converting Enzymes; Enzyme Inhibitors; Glycopeptides; Heart; Lipids; Lysine; Male; Metalloendopeptidases; Myocardium; Oligopeptides; Organ Size; Organophosphonates; Peptides, Cyclic; Perfusion; Piperidines; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Thiorphan; Vasoconstriction | 2010 |
Incidence and risk factors for tenofovir-associated renal function decline among Thai HIV-infected patients with low-body weight.
Topics: Adenine; Adult; Anti-HIV Agents; Body Mass Index; Body Weight; Cohort Studies; Drug Interactions; Female; Glomerular Filtration Rate; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Organophosphonates; Renal Insufficiency; Retrospective Studies; Risk Factors; Tenofovir; Thailand | 2010 |
Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.
Topics: Adenine; Adult; Anti-HIV Agents; Asian People; Body Weight; Cohort Studies; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kidney; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Retrospective Studies; Tenofovir | 2011 |
Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201).
Topics: Adenoviridae; Administration, Intranasal; Animals; Body Weight; Cidofovir; Cytosine; Female; Genetic Vectors; Interferon-alpha; Mice; Mice, Inbred BALB C; Organophosphonates; Protective Agents; Respiratory Tract Infections; Survival Analysis; Time Factors; Vaccinia; Vaccinia virus | 2011 |
Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection.
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Body Weight; Demography; Dideoxynucleosides; Female; Glomerular Filtration Rate; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Multivariate Analysis; Organophosphonates; Risk Factors; Tenofovir | 2012 |
Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases.
Topics: Adenine; Adult; Anti-HIV Agents; Body Weight; Drug Therapy, Combination; Female; Glycosuria; Humans; Hypophosphatemia; Kidney Tubules; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Proteinuria; Tenofovir; Treatment Outcome | 2004 |
Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
Topics: Animals; Antiviral Agents; Body Weight; Brain; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Heart; Liver; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Oxygen; Purines; Respiratory Tract Infections; Ribavirin; Salivary Glands; Spleen; Treatment Outcome; Vaccinia; Vaccinia virus; Viral Plaque Assay; Viremia | 2004 |
Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats.
Topics: Animals; Body Weight; Conditioning, Operant; Cues; Food; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Male; Nicotine; Nicotinic Agonists; Organophosphonates; Phosphinic Acids; Rats; Rats, Wistar; Reinforcement, Psychology; Self Administration; Tobacco Use Disorder | 2005 |
Diethyl 2-phenyl-2 tellurophenyl vinylphosphonate: an organotellurium compound with low toxicity.
Topics: Animals; Biomarkers; Body Weight; Brain; Dithiothreitol; Kidney; Kinetics; Lipid Peroxidation; Liver; Male; Mice; Organ Size; Organometallic Compounds; Organophosphonates; Oxidation-Reduction; Porphobilinogen Synthase; Rats; Rats, Wistar; Sulfhydryl Compounds; Survival Analysis; Tellurium; Thiobarbituric Acid Reactive Substances | 2006 |
Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats.
Topics: Alanine; Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Eating; Female; Fructose-Bisphosphatase; Gluconeogenesis; Glucose; Hyperglycemia; Insulin; Ketone Bodies; Lactic Acid; Male; Molecular Structure; Organophosphonates; Organophosphorus Compounds; Pancreas; Rats; Rats, Zucker; Triglycerides | 2006 |
Hypokalemia in HIV patients on tenofovir.
Topics: Adenine; Adolescent; Adult; Body Weight; Child; Didanosine; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hypokalemia; Kidney Diseases; Male; Middle Aged; Organophosphonates; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Tenofovir; Time Factors | 2006 |
A biochemical and toxicological study with diethyl 2-phenyl-2-tellurophenyl vinylphosphonate in a sub-chronic intraperitoneal treatment in mice.
Topics: Animals; Ascorbic Acid; Body Weight; Brain; Catalase; Drug Administration Routes; Glutathione; Infusions, Parenteral; Kidney; Liver; Mice; Organ Size; Organometallic Compounds; Organophosphonates; Porphobilinogen Synthase; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Tissue Distribution; Transaminases | 2007 |
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.
Topics: Adenine; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Anti-Retroviral Agents; Antiviral Agents; Body Weight; CD4 Lymphocyte Count; Creatinine; Drug Therapy, Combination; Female; HIV Infections; Humans; Kidney; Kidney Diseases; Male; Organophosphonates; Product Surveillance, Postmarketing; Reverse Transcriptase Inhibitors; Risk Factors; Tenofovir | 2007 |
Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
Topics: Adenine; Adult; Age Factors; Analysis of Variance; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Body Weight; Carbamates; Creatinine; Didanosine; Drug Interactions; Female; Furans; Glomerular Filtration Rate; HIV Infections; HIV-1; Humans; Kidney; Linear Models; Male; Middle Aged; Organophosphonates; Sulfonamides; Tenofovir; Time Factors | 2007 |
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Body Weight; Chemokines; Cidofovir; Cowpox; Cowpox virus; Cytokines; Cytosine; Female; Giant Cells; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates | 2008 |
[Hygienic establishment of maximum permissible concentrations of nitrilotrimethylphosphonic acid and a copper-containing complex in reservoir water].
Topics: Animals; Body Weight; Copper; Dose-Response Relationship, Drug; Female; Guinea Pigs; Lethal Dose 50; Male; Maximum Allowable Concentration; Mice; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Rats; Water Pollutants; Water Pollutants, Chemical | 1984 |
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Brain Neoplasms; Cidofovir; Cytosine; Hemangioma; Incidence; Organophosphonates; Organophosphorus Compounds; Polyomavirus; Rats; Rats, Wistar; Skin Neoplasms; Survival Analysis | 1998 |
Administration of 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) to gravid and infant rhesus macaques (Macaca mulatta): safety and efficacy studies.
Topics: Adenine; Animals; Animals, Newborn; Antiviral Agents; Biological Transport; Body Weight; Female; Immunophenotyping; Macaca mulatta; Maternal-Fetal Exchange; Organophosphonates; Organophosphorus Compounds; Placenta; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Simian Acquired Immunodeficiency Syndrome; Tenofovir; Viral Load | 1999 |
Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis.
Topics: Alanine Transaminase; Animals; Antiviral Agents; Aspartate Aminotransferases; Body Weight; Cidofovir; Cytomegalovirus Infections; Cytosine; Disease Models, Animal; Female; Ganciclovir; Hepatitis, Viral, Animal; Herpesviridae Infections; Liver; Mice; Mice, Inbred BALB C; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Virus Replication | 1999 |
Effect of CGS 26303, an endothelin-converting enzyme-neutral endopeptidase inhibitor, on nitrofen-induced congenital diaphragmatic hernia in the rat.
Topics: Animals; Animals, Newborn; Aspartic Acid Endopeptidases; Body Weight; Disease Models, Animal; Endothelin-Converting Enzymes; Female; Hernia, Diaphragmatic; Hernias, Diaphragmatic, Congenital; Injections, Subcutaneous; Linear Models; Liver; Lung; Metalloendopeptidases; Organ Size; Organophosphonates; Phenyl Ethers; Pregnancy; Proportional Hazards Models; Protease Inhibitors; Rats; Reference Values; Survival Analysis; Tetrazoles | 2000 |
Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
Topics: Animals; Antiviral Agents; Body Weight; Cell Line; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Lung; Mice; Mice, Inbred BALB C; Organophosphonates; Organophosphorus Compounds; Respiratory Tract Infections; Ribavirin; Vero Cells; Viral Plaque Assay | 2000 |
Cidofovir inhibits growth of B16 melanoma cells in vivo.
Topics: Animals; Antineoplastic Agents; Body Weight; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Skin Neoplasms | 2000 |
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
Topics: Administration, Intranasal; Animals; Antiviral Agents; Blood Gas Monitoring, Transcutaneous; Body Weight; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Injections, Intraperitoneal; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates; Organophosphorus Compounds; Respiratory System; Respiratory Tract Infections; Time Factors; Vaccinia; Vaccinia virus; Vero Cells; Viral Plaque Assay; Virus Replication | 2001 |
Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta).
Topics: Adenine; Animals; Anti-HIV Agents; Body Weight; Bone and Bones; Embryonic and Fetal Development; Female; Fetus; Gravidity; Macaca mulatta; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Outcome; Reverse Transcriptase Inhibitors; Somatomedins; Tenofovir | 2002 |
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.
Topics: Administration, Inhalation; Aerosols; Animals; Antiviral Agents; Body Weight; Bronchopneumonia; Cidofovir; Cowpox; Cowpox virus; Cytosine; Female; Injections, Subcutaneous; Lung; Mice; Mice, Inbred BALB C; Organ Size; Organophosphonates; Organophosphorus Compounds; Statistics, Nonparametric | 2002 |
Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
Topics: Animals; Antiviral Agents; Area Under Curve; Body Weight; Chlorocebus aethiops; Cidofovir; Cowpox; Cowpox virus; Cytosine; Disease Models, Animal; Female; Lung; Mice; Mice, Inbred BALB C; Nasal Mucosa; Organophosphonates; Organophosphorus Compounds; Prodrugs; Purines; Statistics, Nonparametric; Vero Cells | 2002 |
Diminished urinary excretion of cycle AMP by rats given disodium ethane-1-hydroxy-1,1-diphosphonate.
Topics: Animals; Body Weight; Calcium; Cyclic AMP; Depression, Chemical; Etidronic Acid; Male; Organophosphonates; Organophosphorus Compounds; Parathyroid Glands; Phosphorus; Rats | 1975 |
Relation between bone mineralization, Ca absorption, and plasma Ca in phosphonate-treated rats.
Topics: Animals; Apatites; Body Weight; Bone and Bones; Calcium; Chemical Phenomena; Chemistry; Crystallization; Epiphyses; Etidronic Acid; Female; Homeostasis; Intestinal Absorption; Male; Minerals; Organophosphonates; Rats | 1977 |
Paradoxical relationship between acetylator phenotype and amonafide toxicity.
Topics: Acetylation; Adenine; Antineoplastic Agents; Body Weight; Female; Humans; Imides; Isoquinolines; Leukopenia; Male; Middle Aged; Naphthalimides; Organophosphonates; Phenotype; Prospective Studies | 1991 |
[Experimental research on the chronic inhalational toxicity of chloracetophon].
Topics: Administration, Inhalation; Animals; Blood; Body Weight; Dose-Response Relationship, Drug; Insecticides; Liver; Lung; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Lung neoplasms in rodents after chronic administration of dimethyl hydrogen phosphite.
Topics: Adenoma; Animals; Body Weight; Brain Neoplasms; Carcinogens; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Hyperplasia; Lung Neoplasms; Male; Mice; Organophosphonates; Organophosphorus Compounds; Phosphites; Precancerous Conditions; Rats; Stomach Neoplasms; Testicular Neoplasms | 1986 |
The role of diphosphonates in osteoporosis of disuse.
Topics: Animals; Body Weight; Bone and Bones; Calcitonin; Calcium; Calcium Radioisotopes; Etidronic Acid; Femur; Fluorides; Hydrocarbons, Chlorinated; Male; Methane; Organophosphonates; Organophosphorus Compounds; Osteoporosis; Rats; Tibia | 1973 |
The effects of disodium etidronate on the reproductive functions and embryogeny of albino rats and New Zealand rabbits.
Topics: Abdomen; Abnormalities, Drug-Induced; Animals; Animals, Newborn; Anophthalmos; Aortic Coarctation; Aortic Valve Stenosis; Body Weight; Chelating Agents; Coloboma; Cryptorchidism; Female; Fetal Death; Fetus; Hydrocephalus; Hydronephrosis; Male; Organophosphonates; Pregnancy; Rats; Reproduction; Retina; Spinal Dysraphism; Testicular Diseases | 1971 |
The effectsof disodium ethane-1-hydroxy-1, 1-diphosphonate (EHDP) on mineral and organic components of rat bone.
Topics: Amino Acids; Animals; Body Weight; Bone and Bones; Bone Matrix; Bone Resorption; Calcium; Chromatography, Gas; Chromatography, Ion Exchange; Collagen; Dose-Response Relationship, Drug; Ethane; Male; Nitrogen; Organ Size; Organophosphonates; Phosphorus; Rats; Sodium; Statistics as Topic; Tibia; Time Factors | 1974 |
Fate and toxicity of orally administered polyethylene polyphosphonates.
Topics: Administration, Oral; Animals; Body Weight; Bone and Bones; Brain Chemistry; Digestive System; Female; Half-Life; Intestinal Absorption; Kidney; Liver; Lung; Male; Molecular Weight; Myocardium; Organ Size; Organophosphonates; Phosphorus Radioisotopes; Polyethylenes; Rats; Tibia | 1973 |
Preliminary safety assessment of disodium etidronate as an additive to experimental oral hygiene products.
Topics: Administration, Oral; Animals; Blood Chemical Analysis; Body Weight; Dentifrices; Dogs; Ethanol; Eye; Female; Kidney; Lethal Dose 50; Liver; Male; Mouth Mucosa; Mouthwashes; Organ Size; Organophosphonates; Rabbits; Rats; Rats, Inbred Strains; Sodium; Vomiting | 1972 |
Effectiveness of diphosphonates in preventing "osteoporosis" of disuse in the rat.
Topics: Animals; Body Weight; Bone and Bones; Bone Development; Bone Resorption; Femur; Immobilization; Minerals; Organophosphonates; Osteoporosis; Rats; Tibia | 1971 |
[Onchocerca dermatosis from Mexico and its therapy with metrifonate].
Topics: Adult; Biopsy; Body Weight; Diagnosis, Differential; Edema; Eosinophilia; Erythema; Humans; Keratosis; Leukocytosis; Male; Mexico; Onchocerciasis; Organophosphonates; Psoriasis; Skin | 1970 |
Induction of hepatic microsomal hydroxylating enzymes by technical piperonyl butoxide and some of its analogs.
Topics: Animals; Anisoles; Biotransformation; Body Weight; Cytochromes; Dioxoles; Enzyme Induction; Ethers, Cyclic; Eugenol; Female; Hexobarbital; Liver; Methyltransferases; Microsomes, Liver; Mixed Function Oxygenases; Nitro Compounds; Organ Size; Organophosphonates; Organothiophosphorus Compounds; Phenobarbital; Rats | 1971 |